Metformin PCD Pharma Franchise Company

Cafoli Lifecare offers one of the widest Metformin portfolios in the Indian PCD segment, with 87 formulations available in tablet form, including plain, sustained-release and combination strengths. Every product is manufactured at WHO-GMP certified facilities and supplied to franchise partners on a monopoly basis.

What is Metformin?

Metformin is a biguanide-class oral antihyperglycaemic agent and the recommended first-line medicine for type 2 diabetes mellitus. It works mainly by reducing hepatic glucose production and improving peripheral insulin sensitivity, lowering blood sugar without causing weight gain. More details are available on MedlinePlus.

Therapeutic Applications

Metformin is prescribed for type 2 diabetes mellitus as monotherapy and in combination regimens, and is widely used by gynaecologists in the management of polycystic ovary syndrome (PCOS). Prescriptions come from consultant physicians, diabetologists, endocrinologists and gynaecologists, giving franchise partners a broad prescriber base.

Why Metformin is a High-Potential Molecule for Distributors

India has one of the largest diabetes populations in the world, and Metformin remains the backbone of oral therapy — it features on the WHO Essential Medicines List and in every major treatment guideline. Because diabetes treatment is lifelong, Metformin generates dependable repeat purchases month after month, and a portfolio of 87 strengths and combinations lets partners serve virtually every prescription pattern in their territory.

Why Choose Cafoli Lifecare

Cafoli Lifecare supports partners with district-wise monopoly rights, WHO-GMP certified manufacturing, DCGI-approved formulations, attractive net rates and a complete promotional input kit. More than 1000 franchise partners across India already work with us.

References

1. MedlinePlus: Metformin
2. PubChem: Metformin
3. WHO Essential Medicines List